Bazaar Alan Lee

Director Bazaar Alan Lee bought 2,250 shares of OFIX at $10.92 on 2025-06-04, extending a recent buying pattern amid -46.5% drawdown from 52-week high.

Bazaar Alan Lee, a director, purchased 2,250 shares at $10.92 on 2025-06-04, bringing his holdings to 30,983 shares. This represents his third consecutive open-market buy at Orthofix within a span of less than a month (prior buys on 2025-05-12 and 2025-05-09), suggesting sustained accumulation during a period of significant stock weakness—the price is currently $10.71, -46.5% from the 52-week high of $20.02, and down 37.6% over the 90-day period. However, context matters: the company reported a net loss of $53,094,000 over its most recent full fiscal year, placing it in a fundamentally challenged position despite 7.1% annual revenue growth. The director's repeated purchases at a depressed absolute price point follow a pattern with no demonstrated timing success in his prior two same-ticker buys (outcomes not yet measurable at 90 days), and his broader cross-ticker track record shows only 2 prior buys with outcomes similarly unproven at scale.

Director Alan Lee Bazaar buys 3,990 shares of OFIX in 2 transactions (May 9–12) at blended average $12.60; third insider buying in 14 days.

Alan Lee Bazaar, a Director, executed 2 purchases totaling 3,990 shares for $50,291.77 at a blended average price of $12.60, increasing his holdings by 16.1% to 28,733 shares. This transaction is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The purchases occurred when the stock was trading 37.9% below its 52-week high of $20.02 and has declined 31.4% over the past 90 days, suggesting the board-level activity coincides with significant price weakness. However, the company remains unprofitable with $-53,094,000.00 net income over its most recent full fiscal year, despite posting 7.1% annual revenue growth, which presents a mixed backdrop for evaluating the statement made by insider accumulation.